Emerging Therapeutic Approaches to Hepatocellular Carcinoma Timothy M. Pawlik EDUCATIONAL REVIEW – EMERGING THERAPEUTIC APPROACHES TO HEPATOCELLULAR CARCINOMA 20 April 2010 Pages: 1217 - 1218
Surgical Resection of High-Risk Hepatocellular Carcinoma: Patient Selection, Preoperative Considerations, and Operative Technique Mark J. TrutyJean-Nicolas Vauthey EMERGING THERAPEUTIC APPROACHES TO HEPATOCELLULAR CARCINOMA 20 April 2010 Pages: 1219 - 1225
Management of Small Hepatocellular Carcinoma: A Review of Transplantation, Resection, and Ablation William R. Jarnagin Emerging Therapeutic Approaches To Hepatocellular Carcinoma 20 April 2010 Pages: 1226 - 1233
Intra-Arterial Therapies for Hepatocellular Carcinoma: Where Do We Stand? Eleni LiapiJean-Francois H. Geschwind Emerging Therapeutic Approaches to Hepatocellular Carcinoma 20 April 2010 Pages: 1234 - 1246
Systemic Treatment of Hepatocellular Carcinoma: Dawn of a New Era? Andrew X. Zhu EMERGING THERAPEUTIC APPROACHES TO HEPATOCELLULAR CARCINOMA 20 April 2010 Pages: 1247 - 1256
Is Lymphadenectomy a Predictor or Savior for Patients with Gastric Cancer? Hiroya TakeuchiYuko Kitagawa Gastrointestinal Oncology Open access 06 February 2010 Pages: 1257 - 1258
Suitability of 7th UICC N Stage for Predicting the Overall Survival of Gastric Cancer Patients After Curative Resection in China Jingyu DengHan LiangYi Pan Gastrointestinal Oncology 09 March 2010 Pages: 1259 - 1266
New Metastatic Lymph Node Ratio System Reduces Stage Migration in Patients Undergoing D1 Lymphadenectomy for Gastric Adenocarcinoma Ugwuji N. MaduekweGregory Y. LauwersSam S. Yoon Gastrointestinal Oncology 23 January 2010 Pages: 1267 - 1277
Advanced Gastric Cancer with Early Cancer Macroscopic Appearance: Is It Worthy of D2 Lymphadenectomy? Zhe SunZhen-ning WangHui-mian Xu Gastrointestinal Oncology 08 January 2010 Pages: 1278 - 1290
Critical Assessment of Risk Factors for Complications After Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei Akshat SaxenaTristan D. YanDavid L. Morris Gastrointestinal Oncology 29 December 2009 Pages: 1291 - 1301
Postoperative Pancreatic Fistula After Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy: Incidence, Risk Factors, Management, and Clinical Sequelae Akshat SaxenaTerence C. ChuaDavid L. Morris Gastrointestinal Oncology 20 January 2010 Pages: 1302 - 1310
Tumorigenic Role of Podoplanin in Esophageal Squamous-Cell Carcinoma Nur RahadianiJun-ichiro IkedaEiichi Morii Gastrointestinal Oncology 12 January 2010 Pages: 1311 - 1323
Resection Margin and Recurrence-Free Survival After Liver Resection of Colorectal Metastases Andrea MuratoreDario RiberoLorenzo Capussotti Hepatobiliary and Pancreatic Tumors 22 October 2009 Pages: 1324 - 1329
Impact of the Peritoneal Surface Disease Severity Score on Survival in Patients with Colorectal Cancer Peritoneal Carcinomatosis Undergoing Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Terence C. ChuaDavid L. MorrisJesus Esquivel Colorectal Cancer 22 December 2009 Pages: 1330 - 1336
High Level of Notch1 Protein is Associated with Poor Overall Survival in Colorectal Cancer Dake ChuYunming LiGang Ji Colorectal Cancer 08 January 2010 Pages: 1337 - 1342
Management of Recurrent Rectal Cancer Philippe BouchardJonathan Efron Colorectal Cancer 30 December 2009 Pages: 1343 - 1356
Anterior Perineal PlanE for Ultralow Anterior Resection of the Rectum (The APPEAR Technique): A Video Demonstration Khalid A. El-GendyJamie MurphyNorman S. Williams Colorectal Cancer 29 December 2009 Pages: 1357 - 1358
Distal Pancreatectomy Combined with Celiac Axis Resection in Treatment of Carcinoma of the Body/Tail of the Pancreas: A Single-Center Experience Xubo WuRan TaoChenghong Peng Pancreatic Tumors 03 March 2010 Pages: 1359 - 1366
A Systematic Review and Meta-Analysis of Oncologic Outcomes of Pre- Versus Postoperative Radiation in Localized Resectable Soft-Tissue Sarcoma Emad Al-AbsiForough FarrokhyarMichelle Ghert Bone and Soft Tissue Sarcomas 09 March 2010 Pages: 1367 - 1374
Improving Breast Cancer Surgery: A Classification and Quadrant per Quadrant Atlas for Oncoplastic Surgery Krishna B. CloughGabriel J. KaufmanIsabelle M. Sarfati Breast Oncology 06 February 2010 Pages: 1375 - 1391
Topoisomerase 2 Alpha and the Case for Individualized Breast Cancer Therapy Ronan W. GlynnNicola MillerMichael J. Kerin Breast Oncology 09 March 2010 Pages: 1392 - 1397
p53 as a Marker of Prognosis in African-American Women with Breast Cancer Keith A. DookeranJames J. DignamSarah Gehlert Breast Oncology 05 January 2010 Pages: 1398 - 1405
Metastatic Potential of T1 Breast Cancer can be Predicted by the 70-gene MammaPrint Signature Stella MookMichael KnauerEmiel J. Rutgers Breast Oncology 22 January 2010 Pages: 1406 - 1413
Validation Study of the S Classification for Melanoma Patients with Positive Sentinel Nodes: The Montreal Experience Rami YounanA. BougrineS. Meterissian Melanomas 04 February 2010 Pages: 1414 - 1421
The Diminishing Role of Transurethral Resection of the Prostate Ray M. MerrillBradley D. Hunter Urologic Oncology 21 January 2010 Pages: 1422 - 1428
KRAS and BRAF Mutational Status in Primary Colorectal Tumors and Related Metastatic Sites: Biological and Clinical Implications Antoine ItalianoIsabelle HosteinFlorence Pedeutour Translational Research and Biomarkers 05 January 2010 Pages: 1429 - 1434
Difference Between Proximal and Distal Microsatellite-Unstable Sporadic Colorectal Cancers: Analysis of Clinicopathological and Molecular Features and Prognoses Young-Ho KimByung-Hoon MinJae J. Kim Translational Research and Biomarkers 05 January 2010 Pages: 1435 - 1441
EMAP II-Based Antiangiogenic-Antiendothelial In Vivo Combination Therapy of Pancreatic Cancer Roderich E. SchwarzNiranjan AwasthiMargaret A. Schwarz Translational Research and Biomarkers 30 December 2009 Pages: 1442 - 1452
p21 Waf1/Cip1 Polymorphisms and Risk of Esophageal Cancer Wenjun YangQi QiZhenghao Huo Translational Research and Biomarkers 29 January 2010 Pages: 1453 - 1458
HLA-G Expression in Human Breast Cancer: Implications for Diagnosis and Prognosis, and Effect on Allocytotoxic Lymphocyte Response After Hormone Treatment In Vitro Xu HeDan-dan DongJie Chen Translational Research and Biomarkers 06 January 2010 Pages: 1459 - 1469